19-41349011-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000660.7(TGFB1):​c.356-556T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0618 in 152,106 control chromosomes in the GnomAD database, including 343 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.062 ( 343 hom., cov: 32)

Consequence

TGFB1
NM_000660.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.217

Publications

7 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0755 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFB1NM_000660.7 linkc.356-556T>C intron_variant Intron 1 of 6 ENST00000221930.6 NP_000651.3 P01137A0A499FJK2
TGFB1XM_011527242.3 linkc.356-556T>C intron_variant Intron 1 of 6 XP_011525544.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFB1ENST00000221930.6 linkc.356-556T>C intron_variant Intron 1 of 6 1 NM_000660.7 ENSP00000221930.4 A0A499FJK2
TGFB1ENST00000600196.2 linkc.356-556T>C intron_variant Intron 1 of 5 5 ENSP00000504008.1 A0A7I2YQL8
TGFB1ENST00000677934.1 linkc.356-556T>C intron_variant Intron 1 of 4 ENSP00000504769.1 A0A7I2V5Z9

Frequencies

GnomAD3 genomes
AF:
0.0619
AC:
9401
AN:
151988
Hom.:
341
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0618
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0397
Gnomad ASJ
AF:
0.0424
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0747
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0772
Gnomad OTH
AF:
0.0499
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0618
AC:
9407
AN:
152106
Hom.:
343
Cov.:
32
AF XY:
0.0596
AC XY:
4430
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0616
AC:
2556
AN:
41494
American (AMR)
AF:
0.0397
AC:
606
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0424
AC:
147
AN:
3466
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5170
South Asian (SAS)
AF:
0.0758
AC:
365
AN:
4816
European-Finnish (FIN)
AF:
0.0308
AC:
327
AN:
10602
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0772
AC:
5250
AN:
67996
Other (OTH)
AF:
0.0494
AC:
104
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
447
894
1341
1788
2235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0649
Hom.:
470
Bravo
AF:
0.0613
Asia WGS
AF:
0.0290
AC:
100
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
4.9
DANN
Benign
0.59
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11466321; hg19: chr19-41854916; API